GLPwatch

Study of Patients Being Treated With Anti-obesity Medication

NCT06790160 · Recruiting

Last updated 2026-05-28

This clinical trial is testing how a medication for obesity and overweight affects body composition in adults.

Status Recruiting Currently enrolling participants.
Type Observational
Participants 100 people Planned (estimated).
Who can join Ages 18+ · all sexes
Timeline Started 2025-01 · est. completion 2027-12
Where 1 site · United States

What this study is testing ClinicalTrials.gov NCT06790160 ↗

Description as written by the study sponsor.

The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.

Main thing measuredChange in Total Lean Soft Tissue
SponsorTexas Tech University
Conditions studiedObesity and Overweight
GLP-1 drugs

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT06790160 ↗